In future studies aimed at validating and investigating DS-related mechanisms in models for human brain development, such as cerebral organoids, it will be important to evaluate the effects of single allele mutations for key HSA21 genes (e.g., BRWD1) in DS patient-derived systems and examine DS-related molecular signatures for evidence of genetic contributions and interactions in DS. This evidence concerns the gene BRWD1 and Dravet syndrome.